Fajian He

发表

Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases

J. Tu, Z. Wang, Fangfang Huang, 2022, Stem Cell Research & Therapy.

Nanoscale Zeolitic Imidazolate Framework (ZIF)–8 in Cancer Theranostics: Current Challenges and Prospects

Mengqin Wang, Yuzhou Wu, C. Xie, 2022, Cancers.

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy

C. Xie, Y. Gong, Fajian He, 2022, Frontiers in Immunology.

GPR87 promotes tumor cell invasion and mediates the immunogenomic landscape of lung adenocarcinoma

Jianguo Zhang, C. Xie, Y. Gong, 2022, Communications Biology.

Histone acetylation-related IncRNA: Potential biomarkers for predicting prognosis and immune response in lung adenocarcinoma, and distinguishing hot and cold tumours

Chen Jie, Xinyu Zheng, C. Xie, 2023, Frontiers in Immunology.

SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma

Jianguo Zhang, C. Xie, Jiali Li, 2022, Genes & diseases.

LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer

Jinfang Zhang, C. Xie, Jiali Li, 2022, Clinical and translational medicine.

Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion

Junhong Zhang, Fajian He, Linzhi Han, 2024, Cancer immunology, immunotherapy : CII.

Targeting the LMP1-ALIX axis in EBV+ nasopharyngeal carcinoma inhibits immunosuppressive small extracellular vesicle secretion and boosts anti-tumor immunity.

Fajian He, Yanping Gao, Linzhi Han, 2024, Cancer communications.